Search results
Results From The WOW.Com Content Network
Berlin Patient. The Berlin patient is an anonymous person from Berlin, Germany, who was described in 1998 as exhibiting prolonged "post-treatment control" of HIV viral load after HIV treatments were interrupted. The phrase "Berlin patient" was later used to preserve the anonymity of a different individual claimed to have been functionally cured ...
The Federal Institute for Drugs and Medical Devices (in German: Bundesinstitut für Arzneimittel und Medizinprodukte – BfArM) is the medical regulatory body in Germany. It operates under the Federal Ministry of Health (BMG). It is headquartered in Bonn, Germany. [ 1] Its president is Karl Broich. [ 2]
Non-steroidal anti-inflammatory drugs [1] [3] ( NSAID) [1] are members of a therapeutic drug class which reduces pain, [4] decreases inflammation, decreases fever, [1] and prevents blood clots. Side effects depend on the specific drug, its dose and duration of use, but largely include an increased risk of gastrointestinal ulcers and bleeds ...
You can find instant answers on our AOL Mail help page. Should you need additional assistance we have experts available around the clock at 800-730-2563.
The turnover of the national health sector was about US$368.78 billion (€287.3 billion) in 2010, equivalent to 11.6 percent of gross domestic product (GDP) and about US$4,505 (€3,510) per capita. [ 7] According to the World Health Organization, Germany's health care system was 77% government-funded and 23% privately funded as of 2004. [ 8]
AIDS outbreak at 506 people (as of 31 December 2016, The statistics led from 1 October 1985), of which 255 of them died. The average age of diagnosis is 35 years for men and 39 years for women. In 2018 there was a decrease in diagnoses. There was a decrease of 46 people (citizens and residents) compared to 2017.
Tenofovir is the main HIV drug treatment. The failure to respond to treatment indicates that the virus' resistance to the medication is becoming increasingly common. [182] [183] The United Nations holds its 2016 High-Level Meeting on Ending AIDS. The countries involved, the member states of the United Nations, pledge to end the AIDS epidemic by ...
The initial Swiss HAT (heroin-assisted treatment) trial ("PROVE" study) was conducted as a prospective cohort study with some 1,000 participants in 18 treatment centers between 1994 and 1996, at the end of 2004, 1,200 patients were enrolled in HAT in 23 treatment centers across Switzerland.